| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |